ReviewEndocrine reviews2011

Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes.

Muhammad A Abdul-Ghani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.